SHIVA-CMB: a deep-learning-based robust cerebral microbleed segmentation tool trained on multi-source T2*GRE- and
Ami Tsuchida1,2, Martin Goubet3, Philippe Boutinaud4
1GIN, IMN-UMR5293, CEA, CNRS, Université de Bordeaux, Bordeaux, France.
Scientific Reports
|December 27, 2024
Summary
We developed SHIVA-CMB, a deep learning tool for detecting cerebral microbleeds (CMB) in MRI scans. This open-source detector demonstrates strong generalizability across diverse datasets, aiding research into small vessel disease.
Area of Science:
- Neuroimaging
- Radiology
- Artificial Intelligence
Background:
- Cerebral microbleeds (CMB) are key indicators of cerebral small vessel disease (cSVD), linked to cognitive decline, dementia, and stroke.
- Automated detection of CMB using deep learning (DL) is advancing, but a lack of shared pre-trained models limits their practical use and validation.
Purpose of the Study:
- To introduce the SHIVA-CMB detector, a 3D Unet-based tool for automated CMB detection.
- To address the need for accessible and validated DL models for CMB analysis in research settings.
Main Methods:
- Developed a 3D Unet-based deep learning tool (SHIVA-CMB).
- Trained the model on 450 MRI scans from six diverse cohort studies (T2*- and susceptibility-weighted imaging).
- Evaluated performance on held-out test sets and an independent multi-center cohort, comparing against expert ratings.
Main Results:
- Achieved high sensitivity (0.67), precision (0.82), and F1 score (0.74) on a held-out test set with low false positives.
- Demonstrated robust performance on unseen data and strong correlation (R=0.89) with expert visual CMB counts in a large cohort.
- Publicly released the SHIVA-CMB pipeline and pre-trained models to the research community.
Conclusions:
- The SHIVA-CMB detector is a generalizable and accurate tool for automated CMB detection.
- Public sharing of the tool and models facilitates broader research into cSVD pathophysiology and consequences.
- Enables rapid characterization of CMB in large-scale studies, accelerating neuroimaging research.


